Clinical Trial Update: Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock [Phase 3]

View source ↗

Summary

A Phase 3 trial update comparing norepinephrine alone versus norepinephrine plus dobutamine in cardiogenic shock; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Dobutamine (dobutamine)
• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cardiogenic Shock | Phase 3 | Status: UNKNOWN